Navigation Links
AM-Pharma Announces Positive Results of Phase IIa Clinical Trial,with Alkaline Phosphatase For Ulcerative Colitis

that this first AP study for ulcerative colitis revealed our treatment to be clinically active, despite the short seven day treatment period and the severity of the patients' disease. These results are very promising for the future development of AP for ulcerative colitis, where we plan to administer AP treatment for longer periods. Also importantly, results from this trial revealed that the treatment is very well tolerated. This is potentially good news for ulcerative colitis sufferers, who are looking for safe and effective treatment options."

AM-Pharma will continue to study the oral use of AP for ulcerative colitis in a further Phase II clinical study. Once safety and efficacy have been confirmed in a larger group of patients, AM-Pharma intends to license the product to a partner who will take on the late-stage development and worldwide commercialisation of AP.

Notes to editors:

About AM-Pharma www.am-pharma.com AM-Pharma is a biopharmaceutical company focused on the preclinical and clinical development of novel compounds in the field of severe infectious diseases and inflammatory diseases. All its products are based on endogenous molecules which have been optimised to combat disease.

AM-Pharma is currently conducting Phase II clinical trials for two products; Alkaline Phosphatase for sepsis, acute renal failure and ulcerative colitis; and Anti-microbial Peptide hLF1-11 for the prevention of infections in hemopoietic stem cell transplant patients.

AM-Pharma is based in Bunnik, The Netherlands with a staff of 20. The company is financed by, amongst others, Forbion Capital Partners, Inventages Venture Capital and Theratase plc. Once product safety and efficacy have been established, AM-Pharma will look for world-wide development and marketing partners for its products.

About Alkaline Phosphatase (AP)

The endogenous enzyme Alkaline Phosphatase is expr
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. AM-Pharma Announces Positive Results of a Phase IIa Clinical Trial with Alkaline Phosphatase in Acute Renal Failure
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
(Date:7/11/2014)... 11, 2014 According to a ... Devices Market (Endoscopes, Endoscopic Operative Devices, and Visualization Systems) ... Forecast, 2013-2019" the global endoscopy devices market was valued ... to grow at a CAGR of 6.8% from 2013 ... 36.9 billion in 2019. Browse the full ...
(Date:7/11/2014)... , July 11, 2014 ... to Safety & Health Expo 2014 were ... move to London , ... attending exhibition.          ... http://photos.prnewswire.com/prnh/20140711/696892-a )      (Photo: ...
(Date:7/10/2014)... , 11. Juli 2014 /PRNewswire/ ... Kameras für die molekulare Bildgebung, einschließlich ... heute die CE-Zulassung für sein Navigator ... kann Dilon das Produkt jetzt europaweit ... den Großteil der europäischen Länder ausgedehnt ...
Breaking Medicine Technology:Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 2Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 3Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 4Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 5Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 6UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 2UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 3UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 4Dilon erhält CE-Zulassung für sein Navigator-Gamma-Sondensystem 2
... Nov. 21 An urgent need for new medicines ... has prompted a growing number of collaborations among academic ... biotechnology companies. As noted today in a symposium at ... Tropical Medicine and Hygiene (ASTMH), these collaborations are opening ...
... , LARGO, Fla., Nov. 20 Unilens ... UVI), which develops, licenses, manufactures, distributes and markets specialty ... first quarter ended September 30, 2009 (FY2010). , Net ... first quarter, 4.4% less then $1,761,526 reported in the ...
Cached Medicine Technology:ASTMH Symposium Showcases Efforts To Meet the Need for New Medicines to Treat Infectious Diseases in Developing Countries 2ASTMH Symposium Showcases Efforts To Meet the Need for New Medicines to Treat Infectious Diseases in Developing Countries 3Unilens Vision Reports Record First Quarter Earnings and Royalty Income 2Unilens Vision Reports Record First Quarter Earnings and Royalty Income 3Unilens Vision Reports Record First Quarter Earnings and Royalty Income 4
(Date:7/11/2014)... Dennis Thompson HealthDay Reporter ... girl born with HIV who was thought to be cured ... tests showing detectable levels of the AIDS-causing virus in her ... now nearly 4 years old, had remained virus-free even though ... old. Doctors had hoped her remission would open the door ...
(Date:7/11/2014)... The Europe Well Intervention Market report defines and segments the ... forecast. The well intervention services market in Europe is estimated ... billion by 2018, at a CAGR of 7% from 2013 ... Well Intervention Market report, to get an idea of the ... segmentation in the Europe well intervention market, and is supported ...
(Date:7/11/2014)... Children who have emergency surgery on weekends are ... death than those who have weekday surgeries, according ... Hopkins researchers noted that the risk of death ... nearly 440,000 simple emergency surgeries that children across ... The surgeries are considered generally safe and ...
(Date:7/11/2014)... 11, 2014 According to a new ... Market by Communication Technology (ZigBee, Z-Wave, Bluetooth, Wi-Fi, NFC, ... Automotive & Transportation, Agriculture) & Geography - Global Trends ... Internet of Things market was worth $1029.5 Billion in ... 2020, at an estimated CAGR of 4.08% from 2014 ...
(Date:7/11/2014)... -- Researchers from The Miriam Hospital have ... 65 have significantly higher rates of smoking than ... impairments were less likely to attempt quitting than ... may not be sufficient for this population. The ... advance of print in the American Journal ...
Breaking Medicine News(10 mins):Health News:Mississippi Girl Thought Cured of HIV Shows Signs of Infection 2Health News:Mississippi Girl Thought Cured of HIV Shows Signs of Infection 3Health News:Europe Well Intervention Services Market is Expected to Reach $3.4 Billion by 2018 - New Report by MicroMarket Monitor 2Health News:Europe Well Intervention Services Market is Expected to Reach $3.4 Billion by 2018 - New Report by MicroMarket Monitor 3Health News:Emergency Surgeries on Weekends Riskier for Kids: Study 2Health News:Internet of Things Technology & Application Market Worth $1423.09 Billion by 2020 – New Report by MarketsandMarkets 2Health News:Internet of Things Technology & Application Market Worth $1423.09 Billion by 2020 – New Report by MarketsandMarkets 3Health News:Internet of Things Technology & Application Market Worth $1423.09 Billion by 2020 – New Report by MarketsandMarkets 4Health News:Miriam Hospital study examines smoking prevalence 2
... hospital CEOs, medical directors, trustees and other hospital,leadership ... Hill on Wednesday, September 19 to call for ... At noon at the Retired,Officers Association Building, they ... and Sherrod Brown (D-OH) on the state of ...
... Now Provides Patients with a LodgeNetRX(TM) On Demand ... Patient Experience Deal Marks First ... S.D. and PITTSBURGH, Sept. 18 ,LodgeNet Entertainment Corporation (Nasdaq: ... today announced the installation of a special, "kid,friendly" LodgeNetRX ...
... accelerometer spell the end of pen-and-paper questionnaires/ , ... out boring questionnaires may soon be obsolete! Well, at ... levels must be monitored by doctors. Thanks to the ... without the hassle of keeping a journal or completing ...
... how they respond to treatment, but now researchers at ... University of Arkansas for Medical Sciences have identified a ... cases and potentially guide therapy in the future. ... years after blood stem cell transplant to create a ...
... challenges to treating infectious diseases and developing preventive vaccines ... the immune T-cell response over time. An Emory-led team ... chronic viral infections are able to evade the immune ... in the Proceedings of the National Academy of Sciences. ...
... "...what a real adventure it is for a parent to ... is the story of my adventures,with Zachary between those two ... you to be a better person and to rely on,your ... designer and host of TLC,s ,Overhaulin, WASHINGTON, Sept. 18 ...
Cached Medicine News:Health News:Children's Hospitals in Washington to Lobby Congress to Reauthorize SCHIP Now 2Health News:LodgeNet Deploys Customized 'Kid Friendly' Solution With Children's Hospital of Pittsburgh of UPMC 2Health News:LodgeNet Deploys Customized 'Kid Friendly' Solution With Children's Hospital of Pittsburgh of UPMC 3Health News:Story tips for journalists 2Health News:Story tips for journalists 3Health News:Gene profiling can single out the worst cases of multiple myeloma and guide therapy 2Health News:Gene profiling can single out the worst cases of multiple myeloma and guide therapy 3Health News:Chronic infection persists by targeting stromal cell network in lymphoid organs 2Health News:Old at Age 3: The Inspiring Life of Progeria Patient Zachary Moore 2Health News:Old at Age 3: The Inspiring Life of Progeria Patient Zachary Moore 3Health News:Old at Age 3: The Inspiring Life of Progeria Patient Zachary Moore 4
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: